Drugs / modified extract of Olea europaea pollen
modified extract of Olea europaea pollen
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00831025 | Jan 2008 → Jan 2013 | allergic rhinitis | Laboratorios Leti, S.L. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | modified extract of Olea europaea pollen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00831025 ↗ |
| Modality | Other / unclassified | “modified allergen extract of Olea europaea pollen” NCT00831025 ↗ |
| Route | Subcutaneous | “Depigmented and polymerized allergen extract of Olea europaea pollen for subcutaneous injection.” NCT00831025 ↗ |